Breast Cancer

Papers
(The TQCC of Breast Cancer is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K–AKT pathway123
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer48
Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer40
Exploration of treatment strategies and susceptibility gene of postoperative nausea and vomiting in breast cancer patients: a randomised controlled trial34
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study32
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients31
Long-term local control and cosmesis of perioperative interstitial brachytherapy for partial breast irradiation following breast-conserving surgery29
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy27
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu26
Impact of breast size and composition on the accuracy of mammography and ultrasonography in breast cancer screening26
Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition24
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer23
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers22
Hub metastatic gene signature and risk score of breast cancer patients with small tumor sizes using WGCNA20
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors20
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field20
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?20
An insight into the role of innate immune cells in breast tumor microenvironment19
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer19
Biology of primary breast cancer in older women beyond routine biomarkers18
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients18
Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in Japan18
Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer17
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer 17
The safety of performing breast reconstruction during the COVID-19 pandemic15
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow14
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line14
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors13
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study13
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer13
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry13
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma12
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer12
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud11
The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®11
Diagnostic performance of dedicated breast positron emission tomography11
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis11
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results11
A novel ADC targeting cell surface fibromodulin in a mouse model of triple-negative breast cancer10
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review10
Development and implementation of a decision aid for post-mastectomy breast reconstruction for Japanese women with breast cancer: a field-testing study10
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study10
miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast10
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort10
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial10
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients10
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer10
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can9
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer9
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition9
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”9
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan9
Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study9
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan9
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap8
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression8
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases8
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort8
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern8
Advances in the study of autophagy in breast cancer8
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients8
Performance analysis of screening mammography in Asian women under 40 years8
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes8
Average lifespan shortened due to breast cancer in Australia, 1990–20157
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy7
Comparison of short-term outcomes between pedicled- and free-flap autologous breast reconstruction: a nationwide inpatient database study in Japan7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study7
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study7
Acknowledgments to reviewers 20227
Conservative axillary surgery is emerging in the surgical management of breast cancer7
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer7
Defer surgery in operable breast cancer: how long is too long?7
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I–III breast cancer patients7
Interactions between exposure to polycyclic aromatic hydrocarbons and xenobiotic metabolism genes, and risk of breast cancer7
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ7
Development and internal validation of a predictive model of overall and progression-free survival in eribulin-treated patients with breast cancer based on baseline peripheral blood parameters6
Identifying women with increased risk of breast cancer and implementing risk-reducing strategies and supplemental imaging6
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema6
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties6
Integrin β1 in breast cancer: mechanisms of progression and therapy6
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients6
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer6
Beneficial effects of transdermal administration of tamoxifen on capsular contracture after breast implantation in murine models6
Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD1556
Acknowledgments to reviewers 20246
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction6
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer6
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome6
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence6
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances5
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer5
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants5
The transverse myocutaneous gracilis flap (TMG) for breast reconstruction: ipsi vs. contralateral harvest—aesthetic outcome and refinement procedures5
Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires5
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients5
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway5
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre5
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis5
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer5
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study5
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer5
Dynamic network biomarker to determine the critical point of breast cancer stage progression5
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a mul5
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study5
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition5
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer5
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer5
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection?5
Neurospora crassa is a potential source of anti-cancer agents against breast cancer5
Correction to: The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis5
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy5
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images5
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment5
0.14318418502808